Informationen aus der Gesellschaft - OUP 11/2012

Behandlung der symptomatischen Omarthrose mit Hyaluronsäure
Expertenkonsens im Rahmen des 2. Deutschen Arthrosekongresses in Bonn, 17. März 2012

Prof. Dr. med. Dr. h.c. Jörg Jerosch

Literatur

1. Izquierdo R, Voloshin I, Edwards S et al. American academy of orthopaedic surgeons clinical practice guideline on: the treatment of glenohumeral joint osteoarthritis; Bone Joint Surg Am. 2011; 93): 203–205.

2. Blaine T, Moskowitz R, Udell J, Skyhar M, Levin R, Friedlander J, Daley M, Altman R. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am. 2008; 90: 970–979.

3. Silverstein E, Leger R, Shea KP. The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study.; Am J Sports Med. 2007; 35: 979–985.

4. R Raman, N Day, P Foster, CJ Shaw, GV Johnson .Symptomatic efficacy of viscosupplementation in OA of shoulder – A Prospective study of 100 patients., Efort Congress Nice 2008

5. Noël E, Hardy P, Hagena FW et al., Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study. Joint Bone Spine. 2009; 76): 670–673.

6. Brander VA, Gomberawalla A, Chambers M, Bowen M, Nuber G. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: a prospective, pilot study. PM R. 2010: 2: 259–267.

7. Merolla G, Sperling JW, Paladini P, Porcellini G; Efficacy of Hylan G-F 20 versus 6-methylprednisolone acetate in painful shoulder osteoarthritis: a retrospective controlled trial. Musculoskelet Surg. 2011; 95: 215–224

SEITE: 1 | 2